Acute Hepatitis in Pediatrics
Recruiting now
Conditions studied: Hepatitis
In brief
This study aims to investigate wich symptoms and blood test characteristics acute hepatitis manifests in pediatric age. The study will be conducted because acute hepatitis is not an easily and clearly recognized disease in children. This study aims to better characterize this disease by describing the frequency of the different symptoms with which it can manifest and the changes it causes in blood tests. It also aims to assess the occurrence of any complications of pediatric acute hepatitis. The study is observational, so it is limited to collecting data and analyzing the patient's clinical course without interfering with normal clinical practice.
Key facts
- Study ID
- NCT06761261
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 437
- Starts
- 2023-10-16
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2025-01-07
Who can join
Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 0 and 17 years (extremes included).
- Access to PSP and/or hospitalized (OBI or hospitalization)
- Diagnosis of acute hepatitis
You may not qualify if…
- Refusal of the parent/guardian to participate in the study.
- Mild hypertransaminasemia (\<5 times the upper limit of normal) in a patient with known chronic liver dysfunction (e.g. liver cirrhosis).
- Neonatal jaundice without hepatocyte involvement or signs of cholestasis (prevalence of indirect bilirubin with normal AST, ALT and GGT).
Where it is running
- Azienda USL di Bologna Ospedale Maggiore — Bologna, Italy (enrolling)
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.